GTC Biotherapeutics (fka GTCB)

[keitern]

>>We both have the same goals.<<

We all have the same goats. :)

Interesting discussion re. the regulatory process vis. GTCB's platform. I feel as if this discussion needs further clarity. As a layman, I can see both sides and would like to think there is a difference between the approval of some new "wonder drug" and the approval of an already proven drug that is produced using a more efficient platform. Exactly what are the issues here and what could we realisticaly expect? Let's say that there is enough difference that GTCB can expect, as a rule, the minimum, even though that minimum is still several years. That would be huge in itself as an advantage, no?